183 related articles for article (PubMed ID: 17175244)
1. Vascular endothelial growth factor plays a major role in development of experimental obliterative bronchiolitis.
Krebs R; Hollmén ME; Tikkanen JM; Wu Y; Hicklin DJ; Koskinen PK; Lemström KB
Transplant Proc; 2006 Dec; 38(10):3266-7. PubMed ID: 17175244
[TBL] [Abstract][Full Text] [Related]
2. Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis.
Krebs R; Tikkanen JM; Nykänen AI; Wood J; Jeltsch M; Ylä-Herttuala S; Koskinen PK; Lemström KB
Am J Respir Crit Care Med; 2005 Jun; 171(12):1421-9. PubMed ID: 15778488
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
Rintala SE; Savikko J; Rintala JM; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat.
Kallio EA; Koskinen PK; Aavik E; Vaali K; Lemstöm KB
J Clin Invest; 1997 Dec; 100(12):2984-94. PubMed ID: 9399944
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor in chronic rat allograft nephropathy.
Malmström NK; Kallio EA; Rintala JM; Nykänen AI; Räisänen-Sokolowski AK; Paavonen T; Lemström KB; Koskinen PK
Transpl Immunol; 2008 May; 19(2):136-44. PubMed ID: 18503889
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet-derived growth factor and vascular endothelial growth factor in obliterative airway disease.
Tikkanen JM; Hollmén M; Nykänen AI; Wood J; Koskinen PK; Lemström KB
Am J Respir Crit Care Med; 2006 Nov; 174(10):1145-52. PubMed ID: 16917119
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
9. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
10. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
Krebs R; Tikkanen JM; Ropponen JO; Jeltsch M; Jokinen JJ; Ylä-Herttuala S; Nykänen AI; Lemström KB
Am J Pathol; 2012 Nov; 181(5):1607-20. PubMed ID: 22959907
[TBL] [Abstract][Full Text] [Related]
11. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts.
Farivar AS; Woolley SM; Naidu BV; Fraga CH; Byrne K; Thomas R; Salzman AL; Szabo CS; Mulligan MS
J Heart Lung Transplant; 2004 Aug; 23(8):993-1002. PubMed ID: 15312830
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo.
Arsic N; Zacchigna S; Zentilin L; Ramirez-Correa G; Pattarini L; Salvi A; Sinagra G; Giacca M
Mol Ther; 2004 Nov; 10(5):844-54. PubMed ID: 15509502
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
[TBL] [Abstract][Full Text] [Related]
15. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha.
Farivar AS; Mackinnon-Patterson B; McCourtie AS; Namkung J; Ward PA; Mulligan MS
Exp Mol Pathol; 2005 Jun; 78(3):190-7. PubMed ID: 15924870
[TBL] [Abstract][Full Text] [Related]
16. A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans.
Watanabe T; Okada Y; Hoshikawa Y; Eba S; Notsuda H; Watanabe Y; Ohishi H; Sato Y; Kondo T
Transplant Proc; 2012 May; 44(4):1155-7. PubMed ID: 22564651
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
18. Inducible costimulator blockade prolongs airway luminal patency in a mouse model of obliterative bronchiolitis.
KleinJan A; Willart MA; Kuipers H; Coyle AJ; Hoogsteden HC; Lambrecht BN
Transplantation; 2008 Nov; 86(10):1436-44. PubMed ID: 19034015
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
[TBL] [Abstract][Full Text] [Related]
20. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
